Država: Izrael
Jezik: angleščina
Source: Ministry of Health
SITAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE
K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL
A10BH01
FILM COATED TABLETS
SITAGLIPTIN AS HYDROCHLORIDE MONOHYDRATE 100 MG
PER OS
Required
HETERO LABS LIMITED, INDIA
SITAGLIPTIN
Sitagliptin S.K. is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes melitus. Important limitations of use: Sitagliptin S.K. should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis as it would not be effective in these settings. Sitagliptin S.K. has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitagliptin S.K..
2023-02-12
PATIENT PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS (PREPARATIONS) – 1986 This medicine is marketed upon physician's prescription only SITAGLIPTIN S.K. 25 MG Film-coated tablets EACH FILM-COATED TABLET CONTAINS: Sitagliptin (as hydrochloride monohydrate) 25 mg SITAGLIPTIN S.K.50 MG Film-coated tablets EACH FILM-COATED TABLET CONTAINS: Sitagliptin (as hydrochloride monohydrate) 50 mg SITAGLIPTIN S.K. 100 MG Film-coated tablets Sitagliptin (as hydrochloride monohydrate) 100 mg For a list of inactive ingredients please refer to section 6 “FURTHER INFORMATION”. See also section 2.8 “Important information about some of the ingredients of the medicine”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THIS MEDICINE. • This leaflet contains concise information about Sitagliptin S.K.. If you have any further questions, refer to the doctor or pharmacist • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if it seems to you that their ailment is similar • This medicine is not intended for administration to children and adolescents under 18 years of age 1. WHAT SITAGLIPTIN S.K. IS INTENDED FOR? Sitagliptin S.K. is indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus. IMPORTANT LIMITATIONS OF USE: Sitagliptin S.K. should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. Sitagliptin S.K. has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Sitagliptin S.K. . THERAPEUTIC GROUP : DPP-4 enzyme inhibitors. Sitagliptin S.K. is a member of a class of medicines you take by mouth called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus. 2. BEFORE USING SITAGLIPTIN S.K. 2.1 DO NOT USE SIT Preberite celoten dokument